Non-Small Cell Lung Cancer
Nuvation Bio Inc. focuses its clinical research activity on non-small cell lung cancer, with particular attention to advanced and metastatic disease. The sponsor’s trial portfolio is centered on ROS1-positive lung cancer, reflecting a targeted interest in molecularly defined thoracic oncology.
- ROS1-positive NSCLC
- Advanced and metastatic lung cancer
- Targeted oncology
The research landscape includes international participation across multiple countries and collaborating sites, indicating an active focus on global oncology development within this disease area.
